Download FREE Report Sample
Download Free sampleRaloxifene, primarily used to prevent and treat osteoporosis in postmenopausal women, has been shown to significantly reduce the incidence of vertebral fractures, but the reduction in hip fractures has not been demonstrated.When deciding on the use of raloxifene or other treatments (including estrogen) for postmenopausal women, consideration should be given to menopausal symptoms, effects on uterine and breast tissue, and cardiovascular risk and beneficial effects.
Raloxifene Market contains market size and forecasts of Raloxifene in global, including the following market information:
Global Raloxifene Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Raloxifene Market Sales, 2017-2022, 2023-2028, (M Pcs)
Global top five Raloxifene companies in 2021 (%)
The global Raloxifene market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Original Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Raloxifene include Pharmascience (Joddes Limited), Pd Rx Pharmaceuticals, Lilly, Liberty Pharma, Aurobindo Pharma, Apotex Corporation, Amneal Pharmaceuticals, Actavis (TEVA ) and Jiangsu Hengrui Pharmaceutical. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Raloxifene manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Raloxifene Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Raloxifene Market Segment Percentages, by Type, 2021 (%)
Original Drugs
Generic Drugs
Global Raloxifene Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Raloxifene Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Raloxifene Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Raloxifene Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Raloxifene revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Raloxifene revenues share in global market, 2021 (%)
Key companies Raloxifene sales in global market, 2017-2022 (Estimated), (M Pcs)
Key companies Raloxifene sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pharmascience (Joddes Limited)
Pd Rx Pharmaceuticals
Lilly
Liberty Pharma
Aurobindo Pharma
Apotex Corporation
Amneal Pharmaceuticals
Actavis (TEVA )
Jiangsu Hengrui Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
